- Booz Allen reported an adjusted EPS of $1.55 for the third quarter, exceeding estimates of $1.52 and up from $1.41 year-over-year.
- The company’s revenue for the quarter stood at $2.92 billion, marking a 12% increase compared to the previous year and surpassing the estimated $2.87 billion.
- Cash and cash equivalents decreased by 25% year-over-year, totaling $453.5 million, which fell short of the estimated $503.6 million.
- Market analyst recommendations include 6 buy ratings, 7 hold ratings, and 1 sell rating for Booz Allen.
A look at Booz Allen Hamilton Holding Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Booz Allen Hamilton Holding Corp., a company that provides management and technology consulting services primarily to the U.S. government, has received mixed Smart Scores across different factors. While the company scored high in Growth and Dividend, indicating strong potential for expansion and shareholder returns, it received lower scores in Value and Resilience. This suggests that Booz Allen Hamilton Holding may have some areas of concern in terms of its current valuation and ability to withstand market disruptions. The moderate Momentum score indicates a steady but not rapid pace of performance improvement.
In sum, Booz Allen Hamilton Holding Corp. presents a positive outlook for growth and dividends, but investors may want to keep an eye on valuation and resilience factors. With a focus on providing consulting services to key sectors like defense, intelligence, and civil markets, the company’s performance may be influenced by changes in government spending and policies, making it crucial to monitor market trends and company developments closely.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
